Related references
Note: Only part of the references are listed.SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Lihua Zhu et al.
CELL METABOLISM (2020)
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
Celestino Sardu et al.
DIABETES CARE (2020)
SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?
Armando Rojas et al.
INFLAMMATION RESEARCH (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis
Emanuele Valeriani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Ulf Andersson et al.
MOLECULAR MEDICINE (2020)
CD147 is a Novel Interaction Partner of Integrin αMβ2 Mediating Leukocyte and Platelet Adhesion
David Heinzmann et al.
BIOMOLECULES (2020)
Neutrophil extracelluar traps in COVID-19
Yu Zuo et al.
JCI INSIGHT (2020)
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome
Loris Roncon et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?
Mohsen Kerkeni et al.
MEDICAL HYPOTHESES (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host
Matae Ahn et al.
NATURE MICROBIOLOGY (2019)
Highly glycosylated CD147 promotes hemorrhagic transformation after rt-PA treatment in diabetes: a novel therapeutic target?
Yanan Xie et al.
JOURNAL OF NEUROINFLAMMATION (2019)
HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury
Lei Mi et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes
Dequina A. Nicholas et al.
CELL METABOLISM (2019)
Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE
Jisu Jeong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Association of IFNG gene methylation in peripheral blood cells with the development and prognosis of autoimmune thyroid diseases
Hidemi Hashimoto et al.
CYTOKINE (2019)
Epithelial HMGB1 Delays Skin Wound Healing and Drives Tumor Initiation by Priming Neutrophils for NET Formation
Esther Hoste et al.
CELL REPORTS (2019)
Targeting innate immune mediators in type 1 and type 2 diabetes
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Targeting RAGE Signaling in Inflammatory Disease
Barry I. Hudson et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Emerging Role of High Mobility Group Box-1 in Thrombosis-Related Diseases
Han Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells
Ulf Andersson et al.
SEMINARS IN IMMUNOLOGY (2018)
HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome
Eun Jung Kim et al.
FRONTIERS IN PHYSIOLOGY (2018)
Shared Features of Endothelial Dysfunction between Sepsis and Its Preceding Risk Factors (Aging and Chronic Disease)
Jesus F. Bermejo-Martin et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Emerging role of HMGB1 in lung diseases: friend or foe
Junying Ding et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE
Travis B. Nielsen et al.
MBIO (2017)
Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia
Yan Fei Qi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Therapeutic potential of recombinant thrombomodulin for lung injury after pneumonectomy via inhibition of high-mobility group box 1 in mice
Yusuke Takahashi et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2016)
Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats
Peng Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Therapeutic potential of recombinant thrombomodulin for lung injury after pneumonectomy via inhibition of high-mobility group box 1 in mice
Yusuke Takahashi et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2016)
Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome
Matthieu Jabaudon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
High-mobility group box 1 enhances the inflammatory process in diabetic lung
Raluca Maria Boteanu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
Platelet-derived HMGB1 is a critical mediator of thrombosis
Sebastian Vogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
SOLUBLE RAGE AND THE RAGE LIGANDS HMGB1 AND S100A12 IN CRITICAL ILLNESS: IMPACT OF GLYCEMIC CONTROL WITH INSULIN AND RELATION WITH CLINICAL OUTCOME
Catherine Ingels et al.
SHOCK (2015)
Pattern recognition receptors in innate immunity, host defense, and immunopathology
Rahul Suresh et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2013)
Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products
Laure Yatime et al.
FEBS JOURNAL (2013)
RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA
Cherilyn M. Sirois et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase
H. Fang et al.
CELL DEATH & DISEASE (2013)
Diabetes Alters Activation and Repression of Pro- and Anti-Inflammatory Signaling Pathways in the Vasculature
Elyse Di Marco et al.
Frontiers in Endocrinology (2013)
sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy
Yaseen M. Arabi et al.
CRITICAL CARE (2011)
Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications
W. Bao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands
Narayanam V. Rao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
Shiori Haga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury
T Uchida et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Share Paper
